163 related articles for article (PubMed ID: 35146369)
1. Mortality and disability reported after immunoglobulins or plasmapheresis treatment of Guillain-Barré syndrome.
Meregildo-Rodriguez ED; Bardales-Zuta VH
Infez Med; 2021; 29(4):589-599. PubMed ID: 35146369
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological Pattern and Predictors of Functional Outcome of Patients with Guillain Barre Syndrome at a Tertiary Care Hospital in Pakistan.
Siddiqui M; Majid S; Yusuf H; Mateen F
J Coll Physicians Surg Pak; 2022 Mar; 32(3):364-368. PubMed ID: 35148591
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and real-world outcomes of Guillain-Barré syndrome in the Philippines.
I Espiritu A; Separa KJNJ; Milla FJC; Adiao KJB; Leochico CFD; Jamora RDG
Neurol Res; 2021 Dec; 43(12):995-1004. PubMed ID: 34229572
[TBL] [Abstract][Full Text] [Related]
4. Outcome of Guillain-Barré syndrome following intravenous immunoglobulin compared to natural course.
Kalita J; Misra UK; Chaudhary SK; Das M; Mishra A; Ranjan A; Kumar M
Eur J Neurol; 2022 Oct; 29(10):3071-3080. PubMed ID: 35837807
[TBL] [Abstract][Full Text] [Related]
5. Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU.
Das S; Khan RK; Alam SM; Chowdhury NH; Das P
Mymensingh Med J; 2018 Jul; 27(3):631-640. PubMed ID: 30141456
[TBL] [Abstract][Full Text] [Related]
6. Outcomes in Guillain-Barré Syndrome following a second therapeutic cycle - A single-centre retrospective observational study.
Faustino P; Coutinho M; Brum M; Medeiros L; Ladeira F
J Neurol Sci; 2022 Oct; 441():120368. PubMed ID: 35932547
[TBL] [Abstract][Full Text] [Related]
7. A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt.
Saad K; Mohamad IL; Abd El-Hamed MA; Tawfeek MS; Ahmed AE; Abdel Baseer KA; El-Shemy AS; El-Houfey AA; Tamer DM
Ther Adv Neurol Disord; 2016 Jan; 9(1):3-8. PubMed ID: 26788127
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.
Alanazy MH; Bakry SS; Alqahtani A; AlAkeel NS; Alazwary N; Osman AM; Mustafa RA; Al-Harbi TM; Abdulmana SO; Amper AC; Aldughaythir Y; Ali AS; Makkawi S; Maglan A; Alamoudi L; Alsulaiman F; Alabdali M; AlShareef AA; Abuzinadah AR; Bamaga AK
BMC Neurol; 2021 Jul; 21(1):275. PubMed ID: 34253174
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and complication rates for double-filtration plasmapheresis in patients with Guillain-Barré syndrome.
Lin JH; Tu KH; Chang CH; Chen YC; Tian YC; Yu CC; Hung CC; Fang JT; Yang CW; Chang MY
Transfus Apher Sci; 2015 Feb; 52(1):78-83. PubMed ID: 25544386
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Predictors of Short-Term Outcome in Mexican Adult Patients with Guillain-Barré Syndrome.
Ruiz-Sandoval JL; Salvatella-Gutiérrez AP; López-Valencia G; Chiquete E; Ruiz-Herrera V; Pérez-Gómez HR; Adrián ML; Jiménez-Ruiz A; Rodríguez-Hinojosa J; Quintero-Reyes Á; González-Jaime JJ; Villaseñor Cabrera TJ
Neurol India; 2021; 69(1):107-114. PubMed ID: 33642280
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of various therapeutic modalities for Guillain Barré syndrome in Assiut University Children Hospital.
Mohy-Eldeen ZM; Ahmad AR; Mahran HH; Saad K
Turk J Pediatr; 2020; 62(6):962-969. PubMed ID: 33372434
[TBL] [Abstract][Full Text] [Related]
12. [Classification of pregnancy complicating Guillain-Barré syndrome].
Gu YW; Lin J; Zhang LX; Liang XM; Fan HG; Zhao L; Wang LJ; Yang L
Zhonghua Yi Xue Za Zhi; 2019 May; 99(18):1401-1405. PubMed ID: 31137128
[No Abstract] [Full Text] [Related]
13. Impact of Electrophysiological and Clinical Variants, and Timing of Plasmapheresis on Outcome of Guillain-Barré Syndrome.
Amin B; Meghnathi H; Gajjar MD; Patel T; Vanani J; Gupta N; Chauhan A
J Assoc Physicians India; 2017 Nov; 65(11):14-15. PubMed ID: 29322703
[TBL] [Abstract][Full Text] [Related]
14. Differences in patterns of progression in demyelinating and axonal Guillain-Barré syndromes.
Hiraga A; Mori M; Ogawara K; Hattori T; Kuwabara S
Neurology; 2003 Aug; 61(4):471-4. PubMed ID: 12939419
[TBL] [Abstract][Full Text] [Related]
15. Incidence and outcome of Guillain-Barré syndrome in Iceland: A population-based study.
Hafsteinsdóttir B; Ólafsson E; Jakobsson F
Acta Neurol Scand; 2018 Nov; 138(5):454-458. PubMed ID: 30019469
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome in Bangladesh: validation of Brighton criteria.
Islam MB; Islam Z; Farzana KS; Sarker SK; Endtz HP; Mohammad QD; Jacobs BC
J Peripher Nerv Syst; 2016 Dec; 21(4):345-351. PubMed ID: 27616152
[TBL] [Abstract][Full Text] [Related]
17. Management of Guillain-Barré syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India.
Kishore CK; Vijayabhaskar J; Vishnu Vardhan R; Sainaresh VV; Sriramnaveen P; Sridhar AV; Varalaxmi B; Sandeep P; Ram R; Vengamma B; Siva Kumar V
Ren Fail; 2014 Jun; 36(5):732-6. PubMed ID: 24593239
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome in patients with a recent history of Zika in Cúcuta, Colombia: A descriptive case series of 19 patients from December 2015 to March 2016.
Arias A; Torres-Tobar L; Hernández G; Paipilla D; Palacios E; Torres Y; Duran J; Ugarte U S; Ardila-Sierra A; Castellanos G
J Crit Care; 2017 Feb; 37():19-23. PubMed ID: 27610587
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré syndrome: subtypes and predictors of outcome from India.
Kalita J; Misra UK; Goyal G; Das M
J Peripher Nerv Syst; 2014 Mar; 19(1):36-43. PubMed ID: 24456386
[TBL] [Abstract][Full Text] [Related]
20. Reducing the economic burden in management of Guillain-Barre syndrome using modified plasmapheresis.
Iyer RR; Shah PH; Roy SS; Suri SK
Asian J Transfus Sci; 2016; 10(2):118-21. PubMed ID: 27605847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
